Page last updated: 2024-08-24

triciribine and perifosine

triciribine has been researched along with perifosine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cseh, A; Szalay, B; Szebeni, B; Vásárhelyi, B1
Cheng, JQ; Coppola, D; Guo, JP1
Bjune, K; Naderi, S; Wierød, L1

Other Studies

3 other study(ies) available for triciribine and perifosine

ArticleYear
[Akt enzyme: new therapeutic target in cancer and diabetes?].
    Orvosi hetilap, 2009, Feb-22, Volume: 150, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Diabetes Mellitus; Enzyme Activation; Humans; Hypoglycemic Agents; Insulin Resistance; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Ribonucleosides

2009
IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation.
    The Journal of biological chemistry, 2011, Oct-28, Volume: 286, Issue:43

    Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Enzyme Activation; Female; Gene Deletion; HEK293 Cells; Heterocyclic Compounds, 3-Ring; Humans; I-kappa B Kinase; Mammary Neoplasms, Animal; Mice; Mice, Knockout; NIH 3T3 Cells; Oxadiazoles; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphorylcholine; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Ribonucleosides; Trans-Activators; Transcription Factors

2011
Inhibitors of AKT kinase increase LDL receptor mRNA expression by two different mechanisms.
    PloS one, 2019, Volume: 14, Issue:6

    Topics: Aminopyridines; Animals; Benzimidazoles; CHO Cells; Cricetinae; Cricetulus; Hep G2 Cells; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Phosphorylcholine; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrimidines; Pyrroles; Quinoxalines; Receptors, LDL; Ribonucleosides; RNA Stability; RNA, Messenger; Transcriptional Activation

2019